Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
2.
Oncogene ; 34(10): 1323-32, 2015 Mar 05.
Article in English | MEDLINE | ID: mdl-24681953

ABSTRACT

STAT (Signal Transducer and Activator of Transcription) transcription factors are constitutively activated in most hematopoietic cancers. We previously identified a target gene, LPP/miR-28 (LIM domain containing preferred translocation partner in lipoma), induced by constitutive activation of STAT5, but not by transient cytokine-activated STAT5. miR-28 exerts negative effects on thrombopoietin receptor signaling and platelet formation. Here, we demonstrate that, in transformed hematopoietic cells, STAT5 and p53 must be synergistically bound to chromatin for induction of LPP/miR-28 transcription. Genome-wide association studies show that both STAT5 and p53 are co-localized on the chromatin at 463 genomic positions in proximal promoters. Chromatin binding of p53 is dependent on persistent STAT5 activation at these proximal promoters. The transcriptional activity of selected promoters bound by STAT5 and p53 was significantly changed upon STAT5 or p53 inhibition. Abnormal expression of several STAT5-p53 target genes (LEP, ATP5J, GTF2A2, VEGFC, NPY1R and NPY5R) is frequently detected in platelets of myeloproliferative neoplasm (MPN) patients, but not in platelets from healthy controls. In conclusion, persistently active STAT5 can recruit normal p53, like in the case of MPN cells, but also p53 mutants, such as p53 M133K in human erythroleukemia cells, leading to pathologic gene expression that differs from canonical STAT5 or p53 transcriptional programs.


Subject(s)
Gene Expression Regulation, Leukemic , Leukemia, Myeloid/genetics , Leukemia, Myeloid/metabolism , STAT5 Transcription Factor/metabolism , Tumor Suppressor Protein p53/metabolism , Binding Sites , Cell Line, Tumor , Cluster Analysis , Gene Expression Profiling , Humans , Promoter Regions, Genetic , Protein Binding , Protein Transport
3.
Leukemia ; 27(1): 159-69, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22868969

ABSTRACT

HOX genes have been implicated as regulators of normal and leukemic stem cell functionality, but the extent to which these activities are linked is poorly understood. Previous studies revealed that transduction of primitive mouse hematopoietic cells with a NUP98HOXA10homeodomain (NA10HD) fusion gene enables a subsequent rapid and marked expansion in vitro of hematopoietic stem cell numbers without causing their transformation or deregulated expansion in vivo. To determine whether forced expression of NA10HD in primitive human cells would have a similar effect, we compared the number of long-term culture-initiating cells (LTC-ICs) present in cultures of lenti-NA10HD versus control virus-transduced CD34(+) cells originally isolated from human cord blood and chronic phase (CP) chronic myeloid leukemia (CML) patients. We found that NA10HD greatly increases outputs of both normal and Ph(+)/BCR-ABL(+) LTC-ICs, and this effect is particularly pronounced in cultures containing growth factor-producing feeders. Interestingly, NA10HD did not affect the initial cell cycle kinetics of the transduced cells nor their subsequent differentiation. Moreover, immunodeficient mice repopulated with NA10HD-transduced CP-CML cells for more than 8 months showed no evidence of altered behavior. Thus, NA10HD provides a novel tool to enhance both normal and CP-CML stem cell expansion in vitro, without apparently altering other properties.


Subject(s)
Cell Differentiation , Cell Proliferation , Hematopoietic Stem Cells/cytology , Homeodomain Proteins/genetics , Leukemia, Myeloid, Chronic-Phase/pathology , Neoplastic Stem Cells/cytology , Nuclear Pore Complex Proteins/genetics , Animals , Antigens, CD34/metabolism , Blotting, Western , Cell Cycle , Cells, Cultured , Colony-Forming Units Assay , Fetal Blood/cytology , Fetal Blood/metabolism , Fusion Proteins, bcr-abl/genetics , Hematopoietic Stem Cells/metabolism , Homeobox A10 Proteins , Homeodomain Proteins/metabolism , Humans , Leukemia, Myeloid, Chronic-Phase/genetics , Leukemia, Myeloid, Chronic-Phase/metabolism , Mice , Mice, Inbred NOD , Mice, SCID , Neoplastic Stem Cells/metabolism , Nuclear Pore Complex Proteins/metabolism , Oncogene Proteins, Fusion , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Receptors, Interleukin-2 , Reverse Transcriptase Polymerase Chain Reaction , Transplantation, Heterologous
SELECTION OF CITATIONS
SEARCH DETAIL
...